Egalitare Research And Health Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.20 M
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 268.37%
- Profit Growth 103.76%
- Ebitda 103.76%
- Net Worth 1.54%
- Total Assets 77.14%
About Egalitare Research And Health Care
Egalitare Research And Health Care Private Limited (ERAHCPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 October 2018 (Six years and three months 17 days old ). Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Sudha Velayudhan and Kalappullimolayil Kunjukuttan serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85100KL2018PTC055143
-
Company No.
055143
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Oct 2018
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Egalitare Research And Health Care?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudha Velayudhan
|
Managing Director | 17-Oct-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kalappullimolayil Kunjukuttan
|
Director | 17-Oct-2018 | Current |
Financial Performance of Egalitare Research And Health Care.
Egalitare Research And Health Care Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 268.37% increase. The company also saw a substantial improvement in profitability, with a 103.76% increase in profit. The company's net worth moved up by a moderate rise of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Egalitare Research And Health Care?
Unlock access to Egalitare Research And Health Care's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Egalitare Research And Health Care?
Unlock and access historical data on people associated with Egalitare Research And Health Care, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Egalitare Research And Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Egalitare Research And Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.